# Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers

> **NCT03817346** · PHASE1 · COMPLETED · sponsor: **Gabather AB** · enrollment: 32 (actual)

## Conditions studied

- Safety and Tolerability

## Interventions

- **DRUG:** GT-002
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03817346
- **Lead sponsor:** Gabather AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-17
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-05-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03817346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03817346, "Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03817346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*